Patent · US Active

Treprostinil derivatives and compositions and uses thereof

US10703706B2 · kind B2 · utility

14Cited by

72References

20Claims

0Family size

Assignee

Corsair Pharma, Inc. · US

Inventors

Xiaoming Zhang · Beijing, CN
Meenakshi S. Venkatraman · Fremont, US
Cyrus K. BECKER · Fremont, US

Key dates

Filing date	Feb 8, 2019
Grant date	Jul 7, 2020
Priority date	—
Expiry date	Feb 8, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.